Our co-founder & CSO, @prat_aleix on precision oncology at @iesebschool : "We need a 360-degree view with all stakeholders to implement the precision medicine"
Thanks, #IESEStudentClub, for an inspiring MBA Healthcare Day 2025!
Moltes gràcies @VIAEmpresa i a #AnaMariaGonzálezFranco per aquest article en què la nostra cofundadora i CEO @patri0608 parla dels inicis de la companyia amb el suport de @barcelonactiva, del nostre test #HER2DX, així com del futur que ens espera.
https://t.co/EBvztUbv7j
🔴 Happening now! @esther_sanfeliu presents the correlation of the #HER2DX genomic test with pathologic features in early-stage HER2+ #breastcancer at @TheUSCAP. #HER2DX offers biological insights beyond standard pathology, potentially enhancing personalized treatment.
📢 New study on HER2DX in early-stage HER2+ breast cancer! 🎉
🔹 48% had treatment changes, 73% with reduced therapy.
🔹 Less intense treatment in 69 pCR-high patients matched multi-agent chemo’s pCR rates.
👉🏻https://t.co/JjpddWbW6v
💡#BreastCancer#HER2Positive#Genomics
HER2DX, a genomic diagnostic test, helped identify patients with early-stage HER2-positive breast cancer with a higher likelihood of achieving a pathological complete response. #bcsm | @OlgaMartnezSez1
https://t.co/7InDISr1te
🗞️ Un estudio coliderado por INCLIVA y el @hospitalclinic-@idibaps confirma el impacto clínico de la prueba genómica HER2DX® en el cáncer de mama HER2+ en etapas tempranas
🔗 https://t.co/hG0nhsfW9n
Today, we honor the incredible contributions of women in every field, every community, and every part of the world. It’s a day to acknowledge progress, recognize challenges, and continue working toward a future built on equality. #IWD#InternationalWomensDay
Muchas gracias @Circuloecuestre y @FundacionFero por ofrecer un espacio para explicar la oncología de precisión de la mano de nuestro CSO y co-founder @prat_aleix en la Charla “Presente y futuro del cáncer” llevada a cabo ayer.
¡Enhorabuena por esta iniciativa!
Promovemos la #innovación apoyando con #AyudasCDTI proyectos como el de @RevealGenomics👇
🔹Creación de test diagnósticos mediante #algoritmos que proporcionan resultados fáciles de interpretar por médicos en el ámbito del #CáncerdeMama 👉 https://t.co/q5mtrQU93C
🎞️Apoyando a través de ayudas #NEOTEC: https://t.co/6uDsFJW7cY
#FondosEuropeos #nextgenerationeu #MRR #PRTR #subvención #tecnología #innovación #oncología #AyudandoCrearFuturo #Agenda2030 #ODS3
Our work isn’t just about innovation—it’s about impact. We are dedicated to developing cutting-edge diagnostic tools that help define the best therapeutic options for patients with cancer, helping them receive the most effective treatment.
#WorldCancerDay#precisiononcology
💫 Proud to share that we have achieved ISO 27001 Certification! Our CTO, @Laiapb, remarks: "This certification reinforces our commitment to data security, confidentiality, and integrity at the highest international standards." Huge thanks to our team for making it happen! 🙌🏻
Moltes gràcies, @barcelonactiva, per convidar-nos a la xerrada "T'acostem a empreses disruptives i innovadores que estan redefinint el mercat laboral", en la qual Ángeles Sebastián, COO, ha parlat dels nous perfils necessaris que ens ajudaran a revolucionar l'#oncologiadeprecisió
Announcing a link between B-cell and T-cell immune infiltration and improved survival rates in #breastcancer survivors. These are integrated into #HER2DX and #TNBCDX, enhancing their role in guiding clinical decisions for HER2+ and TNBC.
More: https://t.co/eOG6ExVTv4